Purchase Today Online Stelera Ustekinumab 130 mg Injection South Africa - Botswana, Lesotho, Mozambique, Namibia, Swaziland, Zimbabwe, Johannesburg, Cape Town, Pretoria, Polokwane, Germiston, Nelspruit . - GLOB MED INDIA PHARMA EXPORTER,South Africa

Stelera Ustekinumab 130 mg Injection

Stelera Ustekinumab 130 mg Injection is a biologic medication used to treat autoimmune and inflammatory conditions. It contains ustekinumab, a monoclonal antibody that targets specific proteins in the immune system (IL-12 and IL-23), helping to reduce inflammation and control disease progression. It is widely prescribed for conditions like psoriasis, psoriatic arthritis, and certain gastrointestinal disorders such as Crohn’s disease.

📞 Contact Details to Place Order

💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: https://globmedindia.com

Composition and Content

Active Ingredient: Ustekinumab
Strength: 130 mg per vial
Form: Injectable solution (intravenous use)
Drug Class: Monoclonal antibody / Immunosuppressant

Ustekinumab works by selectively blocking cytokines (IL-12 and IL-23), which play a key role in inflammatory and immune responses.

How to Use

Administered intravenously (IV infusion) by a qualified healthcare professional.
Usually given in a clinical or hospital setting.
Followed by subcutaneous maintenance doses depending on the condition.

Dosage

Initial dose is weight-based IV infusion (130 mg vial used accordingly).
Maintenance doses are typically given every 8–12 weeks (subcutaneous injection).
Dosage and frequency depend on:
- Body weight
- Disease severity
- Physician’s recommendation

Uses

Stelera Ustekinumab is used in the treatment of:

Moderate to severe plaque psoriasis
Psoriatic arthritis
Crohn’s disease
Ulcerative colitis

Treatment Benefits

Reduces inflammation and immune overactivity
Improves skin lesions in psoriasis
Helps maintain remission in Crohn’s disease
Enhances quality of life in chronic autoimmune disorders

Advantages

Targeted therapy with fewer systemic side effects compared to traditional immunosuppressants
Long dosing interval (every 8–12 weeks)
Effective in patients not responding to conventional treatments
Improves both physical symptoms and long-term disease control

Storage Conditions

Store at 2°C to 8°C (refrigerated)
Do not freeze
Keep in original packaging to protect from light
Do not shake the vial
Use immediately after preparation (as advised by healthcare provider)

Alternative Indian Brands

Some alternative brands containing ustekinumab or similar biologics include:

Stelara Injection (Original brand by Janssen)
Ustecinumab Biosimilars (emerging in India depending on availability)
Other biologics with similar indications (different molecules):
- Adalimumab
- Infliximab

(Note: Alternatives should only be used under medical supervision.)